Moderna’s Reinvention: From Covid-19 Losses to Cutting-Edge Vaccines and Infectious Diseases Research
The Covid-19 vaccine business was left behind. This has been confirmed by the results of pharmaceutical companies that had a serum against the coronavirus in their portfolios. Between them, Modern. The company led by Stéphane Bancel lost 4,343 million euros in 2023 due to the decrease in sales of its anti-Covid antigen. Hence, the laboratory … Read more